Clinical Trials Directory

Trials / Completed

CompletedNCT04714749

Feasibility and Tolerance Study for the Treatment of Varicose Ulcers by Cyanoacrylate Glue (ETUVVE)

Feasibility and Tolerance Study for the Treatment of Varicose Ulcers by Cyanoacrylate Glue

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
38 (actual)
Sponsor
Clinique Pasteur · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Ulcers of the lower limbs are a major public health problem whose management needs to be further improved, particularly in terms of healing time, prevalence and recurrence rate. Ulcers of venous origin, or mixed arteriovenous and predominantly venous, represent the majority of leg ulcers with an estimated proportion of 70 to 80% of cases. These are painful, disabling conditions that are difficult to treat in a lasting way. This study focuses on a treatment strategy with endovascular glue. The advantage of treating ulcers with cyanoacrylate glue is the possibility of occluding the great saphenous vein over its entire length, freeing itself from neurological complications secondary to endovenous thermal techniques (laser, radiofrequency), as well as the possibility of treating by direct puncture any perforators or tributaries feeding the ulcer. This treatment strategy would improve the healing process for a lasting resolution of this pathology. This study aims to describe the feasibility and tolerance of this type of treatment in the resolution of varicose ulcers.

Conditions

Interventions

TypeNameDescription
PROCEDUREEndovenous treatmentTreatment of great saphenous vein (its tributaries and possible incompetent perforators feeding the ulcer) by endovascular cyanoacrylate glue
DEVICECyanoacrylate glueTreatment of great saphenous vein (its tributaries and possible incompetent perforators feeding the ulcer) by endovascular cyanoacrylate glue

Timeline

Start date
2021-01-21
Primary completion
2024-01-30
Completion
2024-01-30
First posted
2021-01-19
Last updated
2026-03-06

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04714749. Inclusion in this directory is not an endorsement.